Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2021-04-26 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated 27 April 2021 from Uni-Bio Science Group Limited informing non-registered shareholders that the 2020 annual report and related circulars are published on the company's website. It includes instructions on how to request printed copies of these documents. The text explicitly states that the annual report and circular are available online and that shareholders can request printed copies. The document itself does not contain the annual report or substantive financial data but is an announcement of the publication of the report and related materials. The document length is about 5,029 characters, which is relatively short and consistent with a notification letter rather than a full annual report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA), not the Annual Report (10-K) itself.
2021-04-26 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of an Annual General Meeting (AGM) for Uni-Bio Science Group Limited. It includes details about the meeting date, location, agenda items such as receiving and adopting audited financial statements, re-election of directors, re-appointment of auditors, and approval of share issuance and repurchase mandates. The document is a formal notice inviting shareholders to attend and vote at the AGM, rather than the actual report or minutes of the meeting. It does not contain financial statements or detailed financial analysis but rather the agenda and procedural information for the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial and contains detailed meeting agenda, consistent with an AGM notice rather than a brief announcement or proxy solicitation.
2021-04-26 English
FORM OF PROXY
AGM Information Classification · 95% confidence The document is a Form of Proxy for use by shareholders at the Annual General Meeting (AGM) of Uni-Bio Science Group Limited. It includes instructions for appointing a proxy to vote on resolutions at the AGM, such as adopting audited financial statements, re-electing directors, appointing auditors, and granting share issuance and repurchase mandates. The content is procedural and related to the AGM meeting arrangements and voting, not the actual AGM presentation materials or the full annual report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms and voting instructions.
2021-04-26 English
GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from Uni-Bio Science Group Limited dated 27 April 2021, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for 28 May 2021. It includes the notice of the AGM, resolutions to be proposed such as the grant of general mandates to issue and repurchase shares, and the re-election of directors. The document also contains explanatory statements and biographical details of directors proposed for re-election. The presence of the notice of AGM, detailed agenda items, and proxy form instructions clearly indicate this is material related to the AGM itself, not just an announcement or a results declaration. The document length (15,000 characters) and content depth confirm it is a full circular for the AGM, which fits the category of AGM Information (AGM-R).
2021-04-26 English
Annual Report 2020
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2020' and contains detailed sections typical of an annual report, including Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Directors' Report, Independent Auditor's Report, and consolidated financial statements. It covers the full fiscal year ended 31 December 2020, with extensive financial data, business review, and strategic outlook. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial statements and management commentary confirms it is the official yearly report covering company activity and full financial performance, matching the definition of an Annual Report (10-K). FY 2020
2021-04-26 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and/or share buybacks by Uni-Bio Science Group Limited. It includes detailed information about share issues, share repurchases, and confirmations related to compliance with listing rules on the Hong Kong Stock Exchange. The content focuses on reporting changes in share capital and share buybacks, which aligns with announcements regarding share capital changes rather than a full financial report or earnings release. The document is not a full annual or interim report, nor is it a regulatory certification or proxy statement. It fits the category of a Share Issue/Capital Change announcement, as it reports on new share issues and share repurchases with relevant details and confirmations.
2021-04-12 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.